WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neil KumarChief Executive Officer2026-05-08950$68.35
$64.93kSell
Neil KumarChief Executive Officer2026-05-0813,973$66.65
$931.30kSell
Neil KumarChief Executive Officer2026-05-085,076$67.35
$341.85kSell
Neil KumarChief Executive Officer2026-05-0813,974$66.65
$931.37kSell
Neil KumarChief Executive Officer2026-05-08950$68.35
$64.93kSell
Neil KumarChief Executive Officer2026-05-085,077$67.35
$341.92kSell
Neil KumarChief Executive Officer2026-05-07450$69.09
$31.09kSell
Neil KumarChief Executive Officer2026-05-0711,217$67.50
$757.09kSell
Neil KumarChief Executive Officer2026-05-0711,217$67.50
$757.09kSell
Neil KumarChief Executive Officer2026-05-078,333$68.38
$569.79kSell

1 of 19

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP18.84%36,900,661$2.44BInsider
Viking Global Performance LLC13.59%26,620,991$1.76BInsider
Viking Global Investors LP9.47%18,555,375$1.23BInsider
Kkr Genetic Disorder LP6.77%13,260,971$876.95MInsider
Vanguard Portfolio Management LLC4.13%8,080,573$534.37MInstitution
Vanguard Capital Management LLC3.96%7,759,495$513.14MInstitution
Neil Kumar3.65%7,139,956$472.17MInsider
Aisling Capital Management LP2.60%5,089,611$336.58MInstitution
Invesco Ltd2.34%4,592,814$303.72MInstitution
Ubs Group Ag1.03%2,026,821$134.03MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO24.73%54.27%Net SellingNet Selling
SMMT1.87%98.13%Net Buying
EXEL35.77%5.71%Net SellingNet Selling
IONS21.56%3.33%Net SellingNet Selling
MDGL6.44%93.56%Net BuyingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 24.73% institutional shareholders, 54.27% Bridgebio Pharma insiders, and 21.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 18.84% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $2.44B.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.